NCT03544554

Brief Summary

The study concluded that HLSB training reduced OAB symptoms among women, improved the quality of their lives, changed their HLSBs, and positively affected their mental states. Thus, a holistic approach to the treatment of women with OAB increased the success of the treatment.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2015

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2016

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

April 13, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 4, 2018

Completed
Last Updated

June 4, 2018

Status Verified

May 1, 2018

Enrollment Period

1.8 years

First QC Date

April 13, 2018

Last Update Submit

May 31, 2018

Conditions

Keywords

Overactive bladderhealthy lifestyle behaviorsquality of life

Outcome Measures

Primary Outcomes (4)

  • Change from baseline Overactive Bladder Questionnaire (OAB-V8) scores at 12 weeks

    12 weeks a between implementation of pre-post test

    Intervention and control group cases were assessed at baseline and week 12. The OAB-v8 is a patient-reported outcome questionnaire which have six point rating system (0-40 scores).

  • Change from baseline King's Health Questionnaire (KHQ) scores at 12 weeks

    12 weeks a between implementation of pre-post test.

    Intervention and control group cases were assessed at baseline and week 12. KHQ is a patient self-administered self-report . The responses in KHQ have four point rating system. The eight subscales scored between 0 (best) and 100 (worst).

  • Change from baseline Brief Symptom Inventory (BSI) scores at 12 weeks

    12 weeks a between implementation of pre-post test

    Intervention and control group cases were assessed at baseline and week 12. The Brief Symptom Inventory (BSI) is a brief form of the Symptom Checklist, The responses in BSI have five point rating system(0-212 scores).

  • Change from baseline Healthy Life Style Behavior Scale II (HLSB II) scores at 12 weeks

    12 weeks a between implementation of pre-post test

    Intervention and control group cases were assessed at baseline and week 12. HLSB II is used to measure the degree of engagement in a health-promoting lifestyle along 6 dimensions. The responses in HLPS II have four point rating system(52-208 scores).

Study Arms (1)

Intervention group and control group

EXPERIMENTAL

This research is planned with semi experimental design

Behavioral: a counseling and training program that consisted of a 45-minute presentation based on Pender's Health Promotion Model. Within the scope of the counseling and training program

Interventions

The intervention group was provided with a counseling and training program that consisted of a 45-minute presentation based on Pender's Health Promotion Model.

Also known as: The control group was not provided with training
Intervention group and control group

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older
  • Being literate
  • Diagnosed with OAB
  • Beginning to receive pharmacological treatment for OAB
  • Volunteering to participate in the study

You may not qualify if:

  • Presence of a perceptual or psychiatric disorder which prevents communicating
  • Presence of a neurological disorder
  • Presence of neurological neuropathy caused by Diabetes Mellitus
  • Second or higher stage pelvic organ prolapse
  • Having an anti-incontinence surgery
  • Being pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Cayir G, Kizilkaya Beji N. The effect of a counseling and training program on the treatment of women with overactive bladder. Psychol Health Med. 2022 Sep;27(8):1726-1738. doi: 10.1080/13548506.2021.1916962. Epub 2021 Apr 19.

MeSH Terms

Conditions

Urinary Bladder, Overactive

Condition Hierarchy (Ancestors)

Urinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Investigator
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: The study sample included 100women (50 for the intervention and 50 for the control group) diagnosed with OAB syndrome. The control group was not provided with training. In addition to the pharmacological treatment, the intervention group was provided with a counseling and training program that consisted of a 45minute presentation based on Pender's Health Promotion Model. They were also given "A Manual for Training on HealthyLifestyleBehaviors among women with OAB". The intervention group was requested to follow a weekly-scheduled bladder training program, keep records on the Urinary Diary form for six weeks. In the first interview and in the third month, the women in the intervention and control groups were administered the Introductory Information Form, Urinary Diary (4day), 24hour Standard Pad Test, OAB-V8, King'sHealthQuestionnaire, Healthy LifestyleBehaviorScaleII, and BriefSymptomInventory. In addition, an Inspection Form was administered in the third month.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor, PhD

Study Record Dates

First Submitted

April 13, 2018

First Posted

June 4, 2018

Study Start

January 1, 2015

Primary Completion

October 30, 2016

Study Completion

March 1, 2017

Last Updated

June 4, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share